319 related articles for article (PubMed ID: 18797262)
21. [Syndrome dopamine dysregulation and deep brain stimulation of the subthalamic nucleus in Parkinson's disease].
Omarova SM; Fedorova NV; Tomskiy AA; Gamaleya AA; Bril' EV; Gubareva NN; Poddubskaya AA
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(12):27-32. PubMed ID: 29376980
[TBL] [Abstract][Full Text] [Related]
22. Unilateral subthalamic nucleus deep brain stimulation contralateral to thalamic stimulation in Parkinson disease.
Samii A; Slimp JC; Goodkin R
Parkinsonism Relat Disord; 2005 Jun; 11(4):257-8. PubMed ID: 15878588
[TBL] [Abstract][Full Text] [Related]
23. Outcome of bilateral subthalamic nucleus stimulation in the treatment of Parkinson's disease: correlation with intra-operative multi-unit recordings but not with the type of anaesthesia.
Lefaucheur JP; Gurruchaga JM; Pollin B; von Raison F; Mohsen N; Shin M; Ménard-Lefaucheur I; Oshino S; Kishima H; Fénelon G; Rémy P; Cesaro P; Gabriel I; Brugières P; Keravel Y; Nguyen JP
Eur Neurol; 2008; 60(4):186-99. PubMed ID: 18667827
[TBL] [Abstract][Full Text] [Related]
24. Electroconvulsive therapy for depression in a Parkinson's disease patient with bilateral subthalamic nucleus deep brain stimulators.
Chou KL; Hurtig HI; Jaggi JL; Baltuch GH; Pelchat RJ; Weintraub D
Parkinsonism Relat Disord; 2005 Sep; 11(6):403-6. PubMed ID: 15994113
[TBL] [Abstract][Full Text] [Related]
25. Effects of DBS, premotor rTMS, and levodopa on motor function and silent period in advanced Parkinson's disease.
Bäumer T; Hidding U; Hamel W; Buhmann C; Moll CK; Gerloff C; Orth M; Siebner HR; Münchau A
Mov Disord; 2009 Apr; 24(5):672-6. PubMed ID: 19185021
[TBL] [Abstract][Full Text] [Related]
26. Differential effects of levodopa and subthalamic nucleus deep brain stimulation on bradykinesia in Parkinson's disease.
Timmermann L; Braun M; Groiss S; Wojtecki L; Ostrowski S; Krause H; Pollok B; Südmeyer M; Ploner M; Gross J; Maarouf M; Voges J; Sturm V; Schnitzler A
Mov Disord; 2008 Jan; 23(2):218-27. PubMed ID: 18044706
[TBL] [Abstract][Full Text] [Related]
27. Influence of deep brain stimulation and levodopa on sensory signs in Parkinson's disease.
Gierthmühlen J; Arning P; Binder A; Herzog J; Deuschl G; Wasner G; Baron R
Mov Disord; 2010 Jul; 25(9):1195-202. PubMed ID: 20629160
[TBL] [Abstract][Full Text] [Related]
28. Subthalamic nucleus stimulation affects fear and sadness recognition in Parkinson's disease.
Péron J; Biseul I; Leray E; Vicente S; Le Jeune F; Drapier S; Drapier D; Sauleau P; Haegelen C; Vérin M
Neuropsychology; 2010 Jan; 24(1):1-8. PubMed ID: 20063943
[TBL] [Abstract][Full Text] [Related]
29. Stimulation of the subthalamic nucleus in a patient with Parkinson disease and essential tremor.
Stover NP; Okun MS; Evatt ML; Raju DV; Bakay RA; Vitek JL
Arch Neurol; 2005 Jan; 62(1):141-3. PubMed ID: 15642861
[TBL] [Abstract][Full Text] [Related]
30. Subthalamic nucleus stimulation in Parkinson's disease patients intolerant to levodopa.
Lyons KE; Davis JT; Pahwa R
Stereotact Funct Neurosurg; 2007; 85(4):169-74. PubMed ID: 17259749
[TBL] [Abstract][Full Text] [Related]
31. Local field potential beta activity in the subthalamic nucleus of patients with Parkinson's disease is associated with improvements in bradykinesia after dopamine and deep brain stimulation.
Ray NJ; Jenkinson N; Wang S; Holland P; Brittain JS; Joint C; Stein JF; Aziz T
Exp Neurol; 2008 Sep; 213(1):108-13. PubMed ID: 18619592
[TBL] [Abstract][Full Text] [Related]
32. Effects of chronic subthalamic stimulation on nonmotor fluctuations in Parkinson's disease.
Witjas T; Kaphan E; Régis J; Jouve E; Chérif AA; Péragut JC; Azulay JP
Mov Disord; 2007 Sep; 22(12):1729-34. PubMed ID: 17557355
[TBL] [Abstract][Full Text] [Related]
33. Management of antiparkinsonian therapy during chronic subthalamic stimulation in Parkinson's disease.
Zibetti M; Cinquepalmi A; Angrisano S; Lanotte M; Lopiano L
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 4():S76-80. PubMed ID: 20123562
[TBL] [Abstract][Full Text] [Related]
34. Impulse control and related disorders in Parkinson's disease patients treated with bilateral subthalamic nucleus stimulation: a review.
Broen M; Duits A; Visser-Vandewalle V; Temel Y; Winogrodzka A
Parkinsonism Relat Disord; 2011 Jul; 17(6):413-7. PubMed ID: 21382739
[TBL] [Abstract][Full Text] [Related]
35. Improved asymmetry of gait in Parkinson's disease with DBS: gait and postural instability in Parkinson's disease treated with bilateral deep brain stimulation in the subthalamic nucleus.
Johnsen EL; Mogensen PH; Sunde NA; Østergaard K
Mov Disord; 2009 Mar; 24(4):590-7. PubMed ID: 19097189
[TBL] [Abstract][Full Text] [Related]
36. Electrode position determined by fused images of preoperative and postoperative magnetic resonance imaging and surgical outcome after subthalamic nucleus deep brain stimulation.
Paek SH; Han JH; Lee JY; Kim C; Jeon BS; Kim DG
Neurosurgery; 2008 Nov; 63(5):925-36; discussion 936-7. PubMed ID: 19005383
[TBL] [Abstract][Full Text] [Related]
37. Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation.
Ardouin C; Voon V; Worbe Y; Abouazar N; Czernecki V; Hosseini H; Pelissolo A; Moro E; Lhommée E; Lang AE; Agid Y; Benabid AL; Pollak P; Mallet L; Krack P
Mov Disord; 2006 Nov; 21(11):1941-6. PubMed ID: 16972268
[TBL] [Abstract][Full Text] [Related]
38. Beta oscillatory activity in the subthalamic nucleus and its relation to dopaminergic response in Parkinson's disease.
Weinberger M; Mahant N; Hutchison WD; Lozano AM; Moro E; Hodaie M; Lang AE; Dostrovsky JO
J Neurophysiol; 2006 Dec; 96(6):3248-56. PubMed ID: 17005611
[TBL] [Abstract][Full Text] [Related]
39. Deep brain stimulation of the subthalamic nucleus improves set shifting but does not affect dual task performance in Parkinson's disease.
Page D; Jahanshahi M
IEEE Trans Neural Syst Rehabil Eng; 2007 Jun; 15(2):198-206. PubMed ID: 17601189
[TBL] [Abstract][Full Text] [Related]
40. Dopamine dysregulation syndrome after deep brain stimulation of the subthalamic nucleus in Parkinson's disease.
De la Casa-Fages B; Grandas F
J Neurol Sci; 2012 Jan; 312(1-2):191-3. PubMed ID: 21872889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
